Cotinga Pharmaceuticals Inc. Stock price Toronto S.E.
Equities
COT
CA22675B2021
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -41.67% | -22.22% | -41.67% |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.18M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.42M | Net income 2019 | -2M -2.71M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.14K | Net cash position 2019 | 24.64K 33.36K | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
1 day | -41.67% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+3.22% | 108B | |
+10.00% | 104B | |
+6.43% | 23.66B | |
-11.52% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-12.97% | 16.19B | |
+4.74% | 13.72B | |
+34.76% | 12.22B |
- Stock
- Equities
- Stock Cotinga Pharmaceuticals Inc.
- Stock Cotinga Pharmaceuticals Inc. - Toronto S.E.